In our sample, amplification or mutation of the EGFR gene, as well as amplification of the PDGFRA and KIT genes, potentially leading to their overexpression, were prevalent in HGG IDH—wildtype glioblastoma. The gene discussed is IDH2; the disease is glioblastoma.